
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®
March 1, 2021
Co-Diagnostics has announced that laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorized Rapid Response COVID-19 Saliva Test, which uses Co-Diagnostics CoPrimer™ technology, is now available through Walgreens Find Care®, allowing consumers a convenient, non-invasive option for PCR-based COVID-19 testing from their own.
Dwight Egan, Co-Diagnostics CEO, stated, “Co-Diagnostics is proud that our technology will be available on an even more widespread basis following this announcement by our trusted partner CRL, one of the largest privately-held clinical testing laboratories in the U.S. We strongly believe in the importance of providing gold-standard PCR diagnostic solutions to as many people as possible, and at-home collection devices are a critical component to achieving this level of accessibility.”
Clinical Reference Laboratory received FDA Emergency Use Authorization (EUA) for its saliva-based COVID-19 RT-PCR test in July 2020. In the FDA filing, the test demonstrated 100 percent sensitivity and specificity. The test incorporates technology from trusted partners DNA Genotek and Co-Diagnostics. Saliva samples are collected in a DNA Genotek OMNIgene® ORAL (OM-505) saliva collection device and tested via patented CoPrimer™ probes and primers developed by Co-Diagnostics (NASDAQ: CODX) to detect SARS-CoV-2 (the virus that causes COVID-19) viral RNA.
“When it comes to testing for COVID-19, Co-Diagnostics has been there from the beginning,” said Kelvyn Cullimore. “Their drive to innovate and respond to the pandemic is evident in CRL’s use of Co-Diagnotics’ technology.”
“Testing continues to be a critical tool to keep Americans safe even as the vaccine rolls out,” said Robert Thompson, CEO at Clinical Reference Laboratory. View the CRL release here.
Walgreens Find Care® is a digital health platform available on the Walgreens app and Walgreens.com. Sold under CRL’s HealthConfirm® brand, the COVID-19 Saliva Test is non-invasive and highly accurate, offering consumers the convenience of self-collecting the test right in their homes without supervision.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp














